Preliminary Study on the Expression and the Clinical Significance of CD133 in Peripheral Blood of Patients with Gastric Adenocarcinoma

Table 3

The average BSV of postoperative CD133 mRNA in PBMCs correlated on the clinicopathological features.

Parameters	𝑛 (%)	Mean ± SD	Statistic	𝑃 value
Gender
Male	45 (64.29%)	0.325±0.170	𝑍=−0.545	0.585
Female	25 (35.71%)	0.293±0.157
Size of tumor (cm)
<5	31 (44.29%)	0.282±0.173	𝑍=−1.413	0.158
≥5	39 (55.71%)	0.338±0.157
Lauren type
Intestinal type	54 (77.14%)	0.311±0.172	𝑍=−0.657	0.511
Diffuse type	16 (22.86%)	0.321±0.145
Histological type
1	23 (32.86%)	0.255±0.149	𝜒^2=4.625	0.099
2	15 (21.43%)	0.315±0.198
3	32 (45.71%)	0.354±0.152
Vascular invasion
Negative	49 (70.00%)	0.293±0.157	𝑍=−1.570	0.116
Positive	21 (30.00%)	0.360±0.178
Lymphatic vessel invasion
Negative	33 (47.14%)	0.252±0.145	𝑍=−2.812	0.005
Positive	37 (52.86%)	0.367±0.165
Invasive depth
𝑇1-2	30 (42.86%)	0.215±0.125	𝑍=−4.237	<0.001
𝑇3-4	40 (57.14%)	0.387±0.154
Lymph node metastasis
Negative	28 (40.00%)	0.228±0.134	𝑍=−3.471	0.001
Positive	42 (60.00%)	0.370±0.161
TNM stage
I-II	30 (42.86%)	0.211±0.129	𝑍=−4.439	<0.001
III-IV	40 (57.14%)	0.389±0.148